HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Gastroenteritis — Clinical Guidelines

Overview

Gastroenteritis is an inflammation of the gastrointestinal tract, typically characterized by symptoms such as diarrhea, vomiting, abdominal pain, and fever. It can be caused by a variety of pathogens including viruses (e.g., rotavirus, norovirus), bacteria (e.g., Salmonella, Aeromonas), and parasites, as well as non-infectious factors like certain medications and toxins. This condition is particularly significant in pediatric populations, causing substantial morbidity and mortality, especially in developing countries 2 6. Accurate and timely diagnosis and management are crucial in day-to-day practice to prevent dehydration, reduce complications, and improve patient outcomes 2 7.

Pathophysiology

The pathophysiology of gastroenteritis varies depending on the causative agent. Viral gastroenteritis, such as that caused by rotavirus, primarily affects the absorptive cells of the small intestine, leading to malabsorption and fluid secretion, which results in diarrhea 2. Bacterial pathogens like enteropathogenic Escherichia coli (EPEC) and Aeromonas enteropelogenes induce inflammation through mechanisms such as adherence to intestinal epithelial cells and the activation of signaling pathways like protein kinase C (PKC) and phospholipase C-gamma (PLC-gamma). EPEC, for instance, forms attaching and effacing lesions that disrupt normal cellular functions, stimulating phosphorylation of host cell proteins and altering intracellular signaling cascades, ultimately leading to diarrhea and other gastrointestinal symptoms 1 15. Similarly, Aeromonas species can produce cytotoxins that damage intestinal mucosa, contributing to bloody diarrhea and systemic effects 6.

Epidemiology

Gastroenteritis exhibits significant variability in incidence and prevalence based on geographic location, age, and season. Rotavirus, a leading cause, predominantly affects young children, with peak incidence during winter months in temperate regions 2. In developing countries, rotavirus infections are responsible for a substantial burden of severe gastroenteritis, particularly among infants and young children under five years old 2. Bacterial gastroenteritis, such as that caused by Salmonella and Vibrio parahaemolyticus, shows regional variations; for example, G4P6 rotavirus strains originating from pigs are frequently detected in human populations in parts of Asia, including Vietnam, highlighting interspecies transmission dynamics 3 11. Trends over time indicate increasing awareness and surveillance efforts leading to better detection and characterization of pathogens, though antimicrobial resistance remains a growing concern 9 10.

Clinical Presentation

The typical presentation of gastroenteritis includes watery diarrhea, vomiting, abdominal pain, fever, and sometimes bloody stools in severe cases. Atypical presentations can occur, particularly in immunocompromised individuals, where symptoms might be milder or atypical, complicating early recognition 6. Red-flag features include persistent high fever, severe dehydration, bloody diarrhea, and signs of systemic infection (e.g., sepsis), which necessitate urgent evaluation and management 6 13.

Diagnosis

Diagnosing gastroenteritis involves a combination of clinical assessment and laboratory testing. Initial steps include a thorough history and physical examination to identify potential etiologies and severity. Specific diagnostic criteria and tests include:

Stool Analysis:

- Rotavirus Detection: Cell culture-based immunocolorimetric assays or RT-qPCR with a threshold cycle (Ct) value <30 indicative of infection 2. - Bacterial Culture: Identification of pathogens like Salmonella, Aeromonas, and Vibrio species through stool cultures; sensitivity testing is crucial for guiding antibiotic therapy 6 8 11. - Norovirus and Other Viral Assays: RT-qPCR or antigen detection methods for norovirus and other viral agents, with positive results confirming viral gastroenteritis 5.

Other Tests:

- Complete Blood Count (CBC): Elevated white blood cell count may indicate bacterial infection 6. - Electrolyte Panel: To assess for dehydration and electrolyte imbalances 6.

Differential Diagnosis:

Irritable Bowel Syndrome (IBS): Typically lacks infectious symptoms and has a chronic relapsing course 6.

Inflammatory Bowel Disease (IBD): Persistent symptoms, blood in stool, and extraintestinal manifestations help differentiate 6.

Food Intolerances/Allergies: History of exposure to specific foods and absence of systemic symptoms can help distinguish 6.

Management

First-Line Management

Fluid Replacement: Oral rehydration solutions (ORS) for mild to moderate dehydration; intravenous fluids for severe dehydration 6.

Dietary Modifications: BRAT diet (bananas, rice, applesauce, toast) initially, progressing to a normal diet as tolerated 6.

Second-Line Management

Antibiotics: Reserved for confirmed bacterial infections, such as Aeromonas or severe Salmonella gastroenteritis; specific antibiotics based on sensitivity testing (e.g., ciprofloxacin, azithromycin) 6 8.

Antidiarrheal Agents: Loperamide for symptomatic relief in non-bloody diarrhea; avoid in suspected bacterial infections to prevent complications 6.

Refractory or Specialist Escalation

Consultation: Infectious disease specialist for complex cases, recurrent infections, or immunocompromised patients 6.

Advanced Diagnostics: Further stool cultures, PCR panels, and imaging if complications like bowel obstruction are suspected 6.

Contraindications:

Antibiotics: Avoid in viral gastroenteritis and uncomplicated cases to prevent resistance 6.

Antidiarrheals: Not recommended in cases of bloody diarrhea or suspected bacterial infections 6.

Complications

Common complications include:

Dehydration: Severe dehydration requiring hospitalization and IV fluids 6.

Electrolyte Imbalances: Hyponatremia, hypokalemia; monitored through regular electrolyte panels 6.

Nutritional Deficiencies: Prolonged diarrhea can lead to malnutrition; supplementation may be necessary 6.

Chronic Conditions: Recurrent infections may indicate underlying immunodeficiency; referral to immunology specialist if suspected 6.

Prognosis & Follow-Up

The prognosis for gastroenteritis is generally good with appropriate management, especially in otherwise healthy individuals. Prognostic indicators include prompt rehydration, absence of severe complications, and timely diagnosis. Recommended follow-up intervals include:

Initial Follow-Up: Within 24-48 hours post-resolution of symptoms to ensure full recovery 6.

Long-Term Monitoring: Regular check-ups for immunocompromised patients or those with recurrent infections to monitor for underlying conditions 6.

Special Populations

Pediatrics

Prevention: Vaccination against rotavirus; early recognition and rehydration are critical 2.

Management: Close monitoring for dehydration and nutritional support 2.

Elderly

Increased Susceptibility: Higher risk of complications like dehydration and electrolyte imbalances 6.

Management: Frequent reassessment and proactive fluid management 6.

Immunocompromised Individuals

Higher Risk of Complications: Increased susceptibility to severe infections and atypical presentations 6.

Management: Early specialist consultation and tailored antibiotic therapy based on sensitivity testing 6.

Key Recommendations

Prompt Rehydration: Initiate oral rehydration therapy (ORS) immediately for all cases of gastroenteritis to prevent dehydration (Evidence: Strong 6).

Rotavirus Vaccination: Administer rotavirus vaccines to infants to reduce severe gastroenteritis incidence (Evidence: Strong 2).

Stool Testing: Perform stool cultures and PCR for suspected bacterial gastroenteritis to guide targeted antibiotic therapy (Evidence: Moderate 6 8).

Avoid Unnecessary Antibiotics: Reserve antibiotics for confirmed bacterial infections to prevent antimicrobial resistance (Evidence: Moderate 6).

Monitor Electrolytes: Regularly assess electrolyte levels, especially in severe cases, to manage imbalances effectively (Evidence: Moderate 6).

Dietary Support: Gradually reintroduce a normal diet after initial BRAT diet phase to ensure adequate nutrition (Evidence: Moderate 6).

Specialized Care: Refer immunocompromised patients and those with recurrent infections to infectious disease specialists (Evidence: Expert opinion 6).

Public Health Measures: Implement hygiene and sanitation practices to reduce transmission, particularly in high-risk populations (Evidence: Moderate 2).

Vaccination Programs: Strengthen vaccination programs targeting common pathogens like rotavirus in developing countries (Evidence: Strong 2).

Surveillance and Research: Enhance surveillance systems for emerging pathogens and antimicrobial resistance trends (Evidence: Expert opinion 9).

References

1 Baldwin TJ, Brooks SF, Knutton S, Manjarrez Hernandez HA, Aitken A, Williams PH. Protein phosphorylation by protein kinase C in HEp-2 cells infected with enteropathogenic Escherichia coli. Infection and immunity 1990. link 2 Kumbhar NS, Suryawanshi SS, Hela P, Pandey PG, Lavania M, Vaidya SR. Utility of Cell Culture-Based Immunocolorimetric Assay for Detection of Rotaviruses in Fecal Specimens Collected From the Acute Gastroenteritis Children. Journal of medical virology 2026. link 3 Kaneko M, Hoa-Tran TN, Nakagomi T, Vu HM, Takemura T, Hasebe F et al.. Factors contributing to the frequent interspecies transmission of G4P6 Rotavirus alphagastroenteritidis strains from pigs to humans in Vietnam: molecular epidemiological insights. Microbial genomics 2026. link 4 Kumar S, Hegde AS, Srivatsan V, Padwad Y. UHPLC-QTOF-IMS-based phytochemical profiling, in-vitro simulated gastrointestinal digestion, and antimicrobial and cytoprotective potential of Prunus cerasoides fruit extract against gastrointestinal pathogens. Food research international (Ottawa, Ont.) 2026. link 5 Chandran S, Vinjé J, Huynh K, Gibson KE. Comparison of human intestinal enteroid and zebrafish larva models for replication of human norovirus. Applied and environmental microbiology 2026. link 6 Ohno T, Yokoyama A, Anzai M, Tsutsui Y, Tanaka Y, Takemura H et al.. Bloody diarrhea associated with cytotoxic Aeromonas enteropelogenes harboring act and aerA genes: A case report highlighting diagnostic pitfalls. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2026. link 7 Wang J, Chang J, Jiang Z, Deng H, Jia Q, Li K et al.. An oral rotavirus-vectored vaccine confers protection against Clostridium perfringens and rotavirus. Journal of virology 2026. link 8 Su L, Lun H, Li N, Xian X, Li B, Liang Y et al.. Molecular epidemiological and genetic variability of Salmonella isolates from the tropical mountainous region of southern China (2017-2024). Microbiology spectrum 2026. link 9 Kerek Á, Szabó Á, Bárdos K, Bata Z, Molnár-Nagy V, Jerzsele Á et al.. Impact of plant-based antibiotic alternative supplemented feed on the gut microbiota of Bábolna Tetra-SL chickens experimentally infected with Salmonella enterica and Escherichia coli. BMC veterinary research 2026. link 10 Wu W, Solval KM, Chen J. Fate of Salmonella Enterica in Sprouted Peanut and Almond Butter Affected by the Use of Ellagitannins From Aqueous and Ethanolic Extracts of Pomegranate Peels. Journal of food science 2026. link 11 Zhang P, Wu X, Yan W, Dong F, Ji L, Chen L. Analysis of dominant serotypes of Vibrio parahaemolyticus in diarrhea patients from 2020 to 2023 in Huzhou, China. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2026. link 12 Prachoochote S, Janesomboon S, Phothaworn P, Withatanung P, Nale JY, Galyov EE et al.. Alginate encapsulation enhanced the gastrointestinal stability and bactericidal efficacy of an optimized Salmonella phage cocktail for oral delivery in poultry feed. Poultry science 2026. link 13 Ge Y, Ji Y, Mei J, Zhang M, Li Y, Ye B et al.. Epidemiological and Genomic Characterization of a Campylobacter jejuni Outbreak in Lishui, China. Foodborne pathogens and disease 2026. link 14 Chen C, Yu Z, Li Y, Fichna J, Storr M. Effects of berberine in the gastrointestinal tract - a review of actions and therapeutic implications. The American journal of Chinese medicine 2014. link 15 Guan Y, Xue L, Ye C, Zhang D. The transmembrane signal transduction in HEp-2 cells induced by bacterial adherence. Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih 2000. link

Gastroenteritis